Analytical Data
-
Gene name
COL3A1
- Application
-
Alternative Names
COL3A1;Collagen alpha-1(III) chain
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P02461
-
Expression Region
1059-1466aa
-
AA Sequence
GK SGDRGESGPA GPAGAPGPAG SRGAPGPQGP RGDKGETGER GAAGIKGHRG FPGNPGAPGS PGPAGQQGAI GSPGPAGPRG PVGPSGPPGK DGTSGHPGPI GPPGPRGNRG ERGSEGSPGH PGQPGPPGPP GAPGPCCGGV GAAAIAGIGG EKAGGFAPYY GDEPMDFKIN TDEIMTSLKS VNGQIESLIS PDGSRKNPAR NCRDLKFCHP ELKSGEYWVD PNQGCKLDAI KVFCNMETGE TCISANPLNV PRKHWWTDSS AEKKHVWFGE SMDGGFQFSY GNPELPEDVL DVHLAFLRLL SSRASQNITY HCKNSIAYMD QASGNVKKAL KLMGSNEGEF KAEGNSKFTY TVLEDGCTKH TGEWSKTVFE YRTRKAVRLP IVDIAPYDIG GPDQEFGVDV GPVCFL
-
Molecular Weight
72 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
COL3A1, a gene that encodes type III collagen, plays a crucial role in the structural integrity and function of various tissues, including blood vessels, skin, and connective tissues. Mutations in COL3A1 are associated with conditions like Ehlers-Danlos syndrome, which is characterized by joint hypermobility and skin fragility. Research into recombinant COL3A1 protein has gained attention for its potential therapeutic applications, such as developing strategies for tissue engineering and regenerative medicine. The production of this recombinant protein allows for the study of its biochemical properties and interaction with other extracellular matrix components, facilitating understanding of its role in health and disease. Moreover, researchers are exploring its potential in drug delivery systems and wound healing therapies, as well as its application in modeling vascular diseases. Given the importance of type III collagen in maintaining tissue structure and function, recombinant COL3A1 provides a valuable tool for both basic research and clinical applications, contributing to advancements in the understanding of connective tissue disorders and the development of innovative treatment strategies.











